Keywords
pituitary adenoma
headache
How to Cite
Abstract
Chemical meningitis has been reported as a rare adverse reaction secondary to the administration of a large number of pharmacological agents, with a clinical presentation and findings in the cerebrospinal fluid (CSF) which can confuse the etiology of the clinical picture, where the diagnosis is based on a process of exclusion of other entities in the central nervous system. The article presents the case of a 36-year-old woman with a history of surgery for resection of pituitary macroadenoma, who is wanted CSF fistula rule by performing a cisterno-CT with water-soluble contrast, presenting after the accomplishment of this, signs and symptoms suggestive of meningitis, put away septic meningitis.
Marinac JS. Drug-and chemical-induced aseptic meningitis: a review of the literature. Ann Pharmacother. 1992;26:813-22.
Crook DW, Phuapradit P, Warrell DA. Bacterial meningitis. In: Weatherall DJ, Ledingham JGG, Warrel DA, editors. Oxford textbook of medicine. 3rd ed. Oxford: Oxford Medical Publications; 1996.
Jolles S, Sewell WA, Leighton C. Druginduced aseptic meningitis: diagnosis and management. Drug Saf. 2000;22(3):215-26.
Nakakoshi T, Moriwaka F, Tashiro K, Nakane K, Miyasaka K. Aseptic meningitis complicating iotrolan myelography. AJNR Am J Neuroradiol. 1991;12:173.
Mallat Z, Vassal T, Naouri JF, Prier A, Laredo JD, Offenstadt G. Aseptic meningoencephalitis after iopamidol myelography. Lancet. 1991;338:252.
Zweifler RM, Rothrock JF. Aseptic meningoencephalitis following iohexol myelography. Neuroradiology. 1995;37:148-9.
Viallon A, Zeni F, Lambert C, et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis. 1999;28:1313-6.
Elkin CM, Levan AM, Leeds NE. Tolerance of iohexol, iopamidol, andmetrizamide in lumbar myelography. Surg Neurol. 1986;26:542-6.
Alexiou J, Deloffre D, Vandresse JH, Boucquey JP, Sintzoff S. Postmyelographic meningeal irritation with iohexol. Neuroradiology. 1991;33:85-6.
Berod T, Knebelmann O, Marjou F. Aseptic meningoencephalitis after iopamidol myelography. Ann Pharmacother. 1993;27:1140.
Cissoko H, Lemesle F, Jonville-Bera AP, Autret-Leca E. Aseptic meningitis after iohexol myelography. Ann Pharmacother. 2000;34:812-3.
Mary R, Veinberg F, Couderc R. Acute meningitidis, acute phase proteinsn and procalcitonin. Ann Biol Clin (Paris). 2003;61:127-37.
Lindquist L, Linne T, Hansson LO, Kalin M, Axelsson G. Value of cerebrospinal fluid analysis in the differential diagnosis of meningitis: a study in 710 patients with suspected central nervous system infection. Eur J Clin Microbiol Infect Dis. 1988;7:374-80.
Bender A, Elstner M, Paul R, Straube A. Severe symptomatic aseptic chemical meningitis following myelography: the role procalcitonin. Neurology. 2009;63:1311-3.
Moris G, García-Monco JC. The challenge of drug-induced aseptic meningitis. Arch Intern Med. 1999;159:1185-94.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.